[1]陈丹丹,董博,欧国峰,等.抗疏强骨颗粒对去卵巢模型大鼠血清ALP及TRACP5b的影响[J].西部中医药,2021,34(05):22-25.[doi:10.12174/j.issn.2096-9600.2021.05.06]
　CHEN Dandan,DONG Bo,OU Guofeng,et al.Influence of Anti-osteoporosis Strengthening Bone Granules on Serum ALP and TRACP5b in Ovariectomized Rats[J].Western Journal of Traditional Chinese Medicine,2021,34(05):22-25.[doi:10.12174/j.issn.2096-9600.2021.05.06]
点击复制

抗疏强骨颗粒对去卵巢模型大鼠血清ALP及TRACP5b的影响
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
34
期数:
2021年05期
页码:
22-25
栏目:
出版日期:
2021-05-15

文章信息/Info

Title:
Influence of Anti-osteoporosis Strengthening Bone Granules on Serum ALP and TRACP5b in Ovariectomized Rats
作者:
陈丹丹1, 董博2, 欧国峰3, 王国柱3, 肖斌3, 陈瑞1, 袁普卫2, 方晴1
1.陕西中医药大学，陕西 咸阳 712046
2.陕西中医药大学附属医院
3.陕西中医药大学第二附属医院
Author(s):
CHEN Dandan1, DONG Bo2, OU Guofeng3, WANG Guozhu3, XIAO Bin3, CHEN Rui1, YUAN Puwei2, FANG Qing1
1.Shaanxi University of Chinese Medicine, Xianyang 712046, China
2.Affiliated Hospital of Shaanxi University of Chinese Medicine
3.The Second Affiliated Hospital of Shaanxi University of Chinese Medicine
关键词:
骨质疏松症; 动物模型; 碱性磷酸酶; 抗酒石酸酸性磷酸酶5b; 抗疏强骨颗粒; 实验研究; 大鼠
Keywords:
osteoporosis; animal model; ALP; TRACP5b; anti-osteoporosis strengthening bone granules; experimental research; rats
分类号:
R681
DOI:
10.12174/j.issn.2096-9600.2021.05.06
摘要:
目的观察抗疏强骨颗粒对去卵巢模型大鼠血清碱性磷酸酶（alkaline phosphatase，ALP）、抗酒石酸酸性磷酸酶5b（tartrate resistant acid phosphatase 5b，TRACP5b）的影响及其可能作用机理。 方法将SD大鼠100只随机分为正常组、模型组、中药（大、中、小剂量）组，每组20只。除正常组外其余动物饲养1周去除卵巢建立骨质疏松大鼠模型，术后1周中药组按照相应剂量给药。观察各组大鼠灌胃前后一般情况、股骨组织病理学改变以及血清ALP、TRACP5b的表达情况。 结果模型组大鼠精神状况较差，毛发颜色晦暗无光泽，体质量下降显著，偶有毛发脱落等；中药组大鼠精神状况尚可，毛发颜色较正常组稍差，体质量轻微下降。HE染色显示模型组大鼠软骨细胞出现量空骨陷窝，细胞核聚缩，且排列不整齐，骨小梁内骨细胞明显减少；中药组软骨细胞排列尚规则，结构尚完整，空骨陷窝较少见，与正常组接近。治疗3月后与模型组相比，中药组大鼠血清ALP、TRACP5b含量均下降，中剂量组含量最低，差异具有统计学意义（P＜0.05）。 结论抗疏强骨颗粒能通过降低去卵巢模型大鼠血清ALP、TRACP5b表达，降低破骨细胞活性，抑制骨吸收，从而治疗绝经后骨质疏松症。
Abstract:
ObjectiveTo observe the effects of anti-osteoporosis strengthening bone granules on ALP and TRACP5b in ovariectomized rats and its possible mechanism. MethodsAll 100 SD rats were randomized into the normal group, the model group, different dosages groups of materia medica (large, moderate and small), 20 rats each group. Except the normal group, the rest of the animals were raised for one week, and the ovaries were removed to establish the osteoporosis rat model, one week after operation, materia medica groups were given the corresponding dosages of herbs. To observe general situations before and after gavage, histopathological changes of femur, the expressions of ALP and TRACP5b of the rats in different groups. ResultsThe mental state of the rats in the model group was poor, the hair color was dull, the body mass decreased significantly, and the hair fell off occasionally; the mental state of the rats in materia medica group was fair, the hair color was slightly worse than that in the normal group, and the body weight decreased slightly. HE staining showed that the chondrocytes in the model group had empty bone lacunae, nuclear condensation and irregular arrangement, and the number of osteocytes in the trabecular bone decreased significantly; the arrangement of chondrocytes in materia medica group was regular, the structure was complete, empty bone lacuna was rare, which was close to the normal group. Compared with the model group, the levels of serum ALP and TRACP5b in materia medica group decreased after three months of treatment, and the level in the moderate dose group was the lowest, the difference had statistical meaning (P<0.05). ConclusionAnti-osteoporosis strengthening bone granules could treat postmenopausal osteoporosis through lowering the expressions of ALP and TRACP5b, reducing the activity of osteoclasts and inhibiting bone resorption.

相似文献/References:

[1]谢栋,陈大军,马国亮,等.原发性骨质疏松症的骨密度与中医脏腑辨证的相关性研究*[J].西部中医药,2015,28(02):82.
[2]梁敏.绝经后骨质疏松症42例护理体会[J].西部中医药,2015,28(12):129.
[3]张彩凤,程卫东△,王彩霞,等.玫参胶囊治疗围绝经期骨质疏松症60例[J].西部中医药,2012,25(05):16.
　ZHANG Cai-feng,CHENG Wei-dong,WANG Cai-xia,et al.MeiShen Capsule in Treating 60 Cases of Menopausal Osteoporosis[J].Western Journal of Traditional Chinese Medicine,2012,25(05):16.
[4]张德宏,李晶.老年骨质疏松症的病因病机及防治原则探析[J].西部中医药,2013,26(03):90.
　ZHANG Dehong,LI Jing.The Etiology, Pathogenesis and Prevention Principles of Senile Osteoporosis[J].Western Journal of Traditional Chinese Medicine,2013,26(05):90.
[5]李晶,宋敏△,罗晓,等.淫羊藿总黄酮对去势大鼠股骨骨组织形态学及生物力学的影响*[J].西部中医药,2014,27(07):13.
　LI Jing,SONG Min,LUO Xiao,et al.Effects of Total Flavonoids of Epimedium on Biodynamics and Bone Morphological Metrology of Ovariectomized Rats[J].Western Journal of Traditional Chinese Medicine,2014,27(05):13.
[6]李非,李红专,叶丙霖.原发性骨质疏松症的中医药研究现状[J].西部中医药,2016,29(03):136.
　LI Fei,LI Hongzhuan,YE Binlin.Research Status of Primary Osteoporosis[J].Western Journal of Traditional Chinese Medicine,2016,29(05):136.
[7]王继宏,杨鹏玲.柴芍抗松汤治疗老年原发性骨质疏松症伴抑郁39例[J].西部中医药,2018,31(10):74.
　WANG Jihong,YANG Pengling.ChaiShao KangSong Decoction in Treating 39 Senile Patients Suffering Primary Osteoporosis Accompanying Depression[J].Western Journal of Traditional Chinese Medicine,2018,31(05):74.
[8]张长彪,彭冉东,赵军,等.益肾地黄汤联合利塞膦酸钠治疗肾阳虚型绝经后骨质疏松症45例[J].西部中医药,2017,30(04):1.
　ZHANG Changbiao,PENG Randong,ZHAO Jun,et al.YiShen Dihuang Tang Combined with Risedronate Sodium in the Treatment for 45 Cases of Postmenopausal Osteoporosis of Kidney Yang Deficiency Type[J].Western Journal of Traditional Chinese Medicine,2017,30(05):1.
[9]董林,雷宁波,邢涛,等.损伤胶囊对绝经后骨质疏松症患者疼痛、骨密度及骨代谢生化指标的影响[J].西部中医药,2017,30(11):8.
　DONG Lin,LEI Ningbo,XING Tao,et al.The Effects of Damage Capsules on the Pain, Bone Mineral Density and Biochemical Markers of Bone Metabolism of Postmenopausal Osteoporosis Patients[J].Western Journal of Traditional Chinese Medicine,2017,30(05):8.
[10]马风英.仙灵骨葆胶囊联合甲氨蝶呤治疗类风湿性关节炎继发骨质疏松症37例[J].西部中医药,2018,31(02):98.
　MA Fengying.XianLing GuBao Capsules Combined with Methotrexate in Treating 37 Rheumatiod Arthritis Patients with Secondary Osteoporosis[J].Western Journal of Traditional Chinese Medicine,2018,31(05):98.

备注/Memo

备注/Memo:
陈丹丹（1980—），女，硕士学位，讲师。研究方向：中药防治骨与关节疾病的临床与基础研究。国家自然科学基金（81473711）；陕西省重点科技创新团队项目（2013KCT-26）。
更新日期/Last Update: 2021-05-15